Xiaomei Gu
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
- Family Practice top 5%
- Medication Adherence and Compliance
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Machine Learning in Bioinformatics 2
- Oncology 8
- Drug Transport and Resistance Mechanisms 4
- Co-authors
- Marin L. Schweizer (2 shared papers)Andrea Holcombe (1 shared paper)Brian C. Lund (1 shared paper)Nattawut Leelakanok (1 shared paper)Patrick Breheny (1 shared paper)Michael M. Graham (1 shared paper)Timothy Ginader (1 shared paper)John J. Sunderland (1 shared paper)
- Journals
- Drug Metabolism and Disposition (3 papers)Acta Pharmaceutica Sinica B (1 paper)Drug Metabolism and Pharmacokinetics (1 paper)Journal of the American Pharmacists Association (1 paper)Analytical Chemistry (1 paper)
- Partner nations
- United StatesChinaSweden
In The Last Decade
Xiaomei Gu
31 papers receiving 668 citations
Peers
Comparison fields: 5 of 111
- Geriatrics and Gerontology 193
- Family Practice 55
- Pharmacology 62
- Oncology 154
- Cardiology and Cardiovascular Medicine 98
Countries citing papers authored by Xiaomei Gu
This map shows the geographic impact of Xiaomei Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Gu more than expected).
Fields of papers citing papers by Xiaomei Gu
This network shows the impact of papers produced by Xiaomei Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Gu. The network helps show where Xiaomei Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomei Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 240 | |
| 2 | 2017 | 87 | |
| 3 | 2016 | 67 | |
| 4 | 2016 | 41 | |
| 5 | 2017 | 38 | |
| 6 | 2014 | 36 | |
| 7 | 2017 | 28 | |
| 8 | 2015 | 22 | |
| 9 | 2016 | 12 | |
| 10 | 2013 | 11 | |
| 11 | 2020 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2016 | 9 | |
| 14 | 2017 | 9 | |
| 15 | 2023 | 9 | |
| 16 | 2020 | 8 | |
| 17 | 2003 | 7 | |
| 18 | 2010 | 6 | |
| 19 | 2012 | 5 | |
| 20 | 2000 | 4 |
About Xiaomei Gu
Xiaomei Gu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 31 papers that have together received 685 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cerebrovascular and Carotid Artery Diseases (2 papers), Metabolism and Genetic Disorders (2 papers), Machine Learning in Bioinformatics (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Geriatrics and Gerontology (193 citations), Family Practice (55 citations), Pharmacology (62 citations), Oncology (154 citations) and Cardiology and Cardiovascular Medicine (98 citations). Xiaomei Gu has collaborated with scholars based in United States, China and Sweden. Frequent co-authors include Marin L. Schweizer, Andrea Holcombe, Brian C. Lund, Nattawut Leelakanok, Patrick Breheny, Michael M. Graham, Timothy Ginader, John J. Sunderland, Ethan Kuperman and Parijat S. Joy. Their work appears in journals such as Drug Metabolism and Disposition, Acta Pharmaceutica Sinica B, Drug Metabolism and Pharmacokinetics, Journal of the American Pharmacists Association and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.